Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma

• Domenica Lorusso,
• Domenica Lorusso,
• Romano Danesi,
• Laura Deborah Locati,
• Laura Deborah Locati,
• Gianluca Masi,
• Gianluca Masi,
• Ugo De Giorgi,
• Angiolo Gadducci,
• Sandro Pignata,
• Roberto Sabbatini,
• Antonella Savarese,
• Giorgio Valabrega,
• Claudio Zamagni,
• Nicoletta Colombo,
• Nicoletta Colombo

Affiliations

Domenica Lorusso

Department of Clinical Research Planning, Fondazione Policlinico Universitario A Gemelli Istituto di Ricerca e Cura a carattere scientifico (IRCCS), Rome, Italy

Domenica Lorusso

Department of Life Science and Public Health, Catholic University of Sacred Heart, Rome, Italy

Romano Danesi

Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Laura Deborah Locati

Translational Oncology Unit, Istituto di Ricerca e Cura a carattere scientifico (IRCCS) Istituti Clinici Scientifici (ICS) Maugeri, Pavia, Italy

Laura Deborah Locati

Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy

Gianluca Masi

Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

Gianluca Masi

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

Ugo De Giorgi

Department of Medical Oncology, Istituto di Ricerca e Cura a carattere scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST), Dino Amadori, Meldola, Italy

Angiolo Gadducci

Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy

Sandro Pignata

0Department of Urology and Gynecology, Istituto Nazionale Tumori Istituto di Ricerca e Cura a carattere scientifico (IRCCS) “Fondazione Giovanni Pascale”, Naples, Italy

Roberto Sabbatini

0Department of Urology and Gynecology, Istituto Nazionale Tumori Istituto di Ricerca e Cura a carattere scientifico (IRCCS) “Fondazione Giovanni Pascale”, Naples, Italy

Antonella Savarese

1Division of Medical Oncology 1, Istituto di Ricerca e Cura a carattere scientifico (IRCCS) -Regina Elena National Cancer Institute, Rome, Italy

Giorgio Valabrega

2University of Torino-Struttura Complessa a Direzione Universitaria (S.C.D.U.) Oncologia Azienda Ospedaliera (A.O) Ordine Mauriziano-Ospedale Umberto I, Torino, Italy

Claudio Zamagni

3Addarii Medical Oncology, Istituto di Ricerca e Cura a carattere scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

Nicoletta Colombo

4School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy

Nicoletta Colombo

5Department of Oncological Gynecology, European Institute of Oncology (IEO) Istituto di Ricerca e Cura a carattere scientifico (IRCCS), Milan, Italy